United States-Israel Defense Partnership Act of 2025
Sponsored By: Representative Wilson (SC)
Introduced
Summary
Would deepen U.S.-Israel defense cooperation by creating new joint programs, offices, and multi-year funding to develop and deploy counter-unmanned systems and other emerging defense technologies.
Show full summary
- U.S. military and Department of Defense: Creates a United States–Israel Counter-Unmanned Systems Program and a program office, authorizes $150 million per year for 2026–2030, and requires annual unclassified reports.
- U.S. and Israeli defense industries and tech firms: Authorizes joint research, testing, and procurement across artificial intelligence, cybersecurity, robotics, quantum, and automation with $50 million per year for 2026–2030 and a framework for cost sharing and intellectual property.
- Regional partners and missile defense planners: Requires an assessment of integrated air and missile defense in the U.S. Central Command area with an unclassified report in 180 days and extends the War Reserves Stockpile Authority beyond January 1, 2029.
*Would authorize $150 million per year for counter-unmanned systems and $50 million per year for emerging technology cooperation from 2026–2030, and raises funding caps for anti-tunnel and counter-UAS programs through 2028.*
Bill Overview
Analyzed Economic Effects
7 provisions identified: 7 benefits, 0 costs, 0 mixed.
More funding for tunnel and drone defenses
The bill would raise funding levels and extend two ongoing US‑Israel programs. Anti‑tunnel work would increase from $50 million to $80 million and run through December 31, 2028. The counter‑drone program would increase from $55 million to $75 million and also run through December 31, 2028. This would keep joint efforts going against tunnels and small drones.
New US-Israel program to stop drones
The bill would create a US‑Israel program to develop, test, and deploy defenses against drones and other unmanned systems. It would authorize $150 million each year for fiscal years 2026 through 2030. The Pentagon would set up a program office, run joint research and training, and share data. It would give Congress an unclassified report within one year and every year after.
US-Israel joint research on new defense tech
The bill would let the Defense Department do joint research with Israel on AI, cybersecurity, robotics, quantum, and automation. It would authorize $50 million each year for fiscal years 2026 through 2030. Work could not start until a report to Congress sets cost‑sharing, intellectual property rules, and semiannual Israeli spending reports. DoD would send Congress a report every six months that includes Israel’s latest spending report.
Defense Innovation Unit office in Israel
The bill would require the Defense Department to open a Defense Innovation Unit office in Israel within 180 days. The office would work with Israel’s defense ministry and private companies. It would share technology and help counter dual‑use threats tied to Iran.
Longer authority for US war stockpiles
The bill would extend an authority date for U.S. war reserve stockpiles tied to Israel. The date would move from after January 1, 2027 to after January 1, 2029. This would keep the authority in place for two extra years.
Study on air and missile defenses
The bill would require a Defense Department study on air and missile defense in the Central Command region. It would review current strength, ways to improve, needed funding, legal authorities, and options to work more with Israel and partners. The study must consider lessons from the April 13, 2024 and October 1, 2024 Iranian attacks on Israel. An unclassified report would be due within 180 days.
Talks on Israel joining defense industrial base
The bill would direct the Defense Department to seek talks with Israel within 90 days about joining the National Technology and Industrial Base. Any engagement would need to protect sensitive information and national security for both countries.
Sponsors & CoSponsors
Sponsor
Wilson (SC)
SC • R
Cosponsors
Norcross
NJ • D
Sponsored 2/12/2025
Nunn (IA)
IA • R
Sponsored 2/21/2025
Gillen
NY • D
Sponsored 2/21/2025
Tenney
NY • R
Sponsored 2/24/2025
Gottheimer
NJ • D
Sponsored 2/24/2025
Fitzpatrick
PA • R
Sponsored 2/25/2025
Wilson (FL)
FL • D
Sponsored 2/25/2025
Moskowitz
FL • D
Sponsored 2/25/2025
Davis (NC)
NC • D
Sponsored 2/25/2025
Reschenthaler
PA • R
Sponsored 2/25/2025
Bishop
GA • D
Sponsored 2/25/2025
Frankel, Lois
FL • D
Sponsored 2/25/2025
Smith (NJ)
NJ • R
Sponsored 2/25/2025
Kiggans (VA)
VA • R
Sponsored 2/25/2025
Scott, David
GA • D
Sponsored 2/25/2025
Crenshaw
TX • R
Sponsored 2/26/2025
Walberg
MI • R
Sponsored 2/26/2025
McBride
DE • D
Sponsored 2/26/2025
Wasserman Schultz
FL • D
Sponsored 2/26/2025
Kean
NJ • R
Sponsored 2/26/2025
Thanedar
MI • D
Sponsored 2/26/2025
Sorensen
IL • D
Sponsored 2/27/2025
Jack
GA • R
Sponsored 2/27/2025
Ryan
NY • D
Sponsored 2/27/2025
Van Drew
NJ • R
Sponsored 2/27/2025
Ezell
MS • R
Sponsored 2/27/2025
Williams (GA)
GA • D
Sponsored 3/3/2025
Elfreth
MD • D
Sponsored 3/3/2025
Lieu
CA • D
Sponsored 3/3/2025
Hunt
TX • R
Sponsored 3/3/2025
Morelle
NY • D
Sponsored 3/3/2025
Lawler
NY • R
Sponsored 3/3/2025
Boyle (PA)
PA • D
Sponsored 3/3/2025
Haridopolos
FL • R
Sponsored 3/3/2025
Strong
AL • R
Sponsored 3/3/2025
Pallone
NJ • D
Sponsored 3/4/2025
Kennedy (NY)
NY • D
Sponsored 3/4/2025
Grothman
WI • R
Sponsored 3/4/2025
Meng
NY • D
Sponsored 3/4/2025
Bresnahan
PA • R
Sponsored 3/4/2025
Harrigan
NC • R
Sponsored 3/4/2025
Suozzi
NY • D
Sponsored 3/4/2025
Rutherford
FL • R
Sponsored 3/4/2025
LaLota
NY • R
Sponsored 3/4/2025
Meeks
NY • D
Sponsored 3/4/2025
Langworthy
NY • R
Sponsored 3/4/2025
Wagner
MO • R
Sponsored 3/5/2025
Wittman
VA • R
Sponsored 3/5/2025
Smith (NE)
NE • R
Sponsored 3/5/2025
Stauber
MN • R
Sponsored 3/5/2025
LaMalfa
CA • R
Sponsored 3/5/2025
Titus
NV • D
Sponsored 3/6/2025
Miller (WV)
WV • R
Sponsored 3/10/2025
Garcia (CA)
CA • D
Sponsored 3/10/2025
Liccardo
CA • D
Sponsored 3/10/2025
Peters
CA • D
Sponsored 3/11/2025
Pappas
NH • D
Sponsored 3/11/2025
Kustoff
TN • R
Sponsored 3/11/2025
Bera
CA • D
Sponsored 3/11/2025
Garbarino
NY • R
Sponsored 3/11/2025
Bilirakis
FL • R
Sponsored 3/18/2025
Gonzales, Tony
TX • R
Sponsored 3/18/2025
Valadao
CA • R
Sponsored 3/18/2025
Bell
MO • D
Sponsored 3/18/2025
Schneider
IL • D
Sponsored 3/18/2025
Landsman
OH • D
Sponsored 3/18/2025
Golden (ME)
ME • D
Sponsored 3/18/2025
Moore (NC)
NC • R
Sponsored 3/18/2025
Jackson (IL)
IL • D
Sponsored 3/18/2025
Clarke (NY)
NY • D
Sponsored 3/18/2025
Houlahan
PA • D
Sponsored 3/18/2025
Barrett
MI • R
Sponsored 3/18/2025
Auchincloss
MA • D
Sponsored 3/18/2025
Brown
OH • D
Sponsored 3/21/2025
Olszewski
MD • D
Sponsored 3/21/2025
Neguse
CO • D
Sponsored 3/21/2025
Lee (NV)
NV • D
Sponsored 3/24/2025
Goldman (NY)
NY • D
Sponsored 3/24/2025
Moulton
MA • D
Sponsored 3/24/2025
Gooden
TX • R
Sponsored 3/24/2025
Salazar
FL • R
Sponsored 3/24/2025
Craig
MN • D
Sponsored 3/24/2025
Van Orden
WI • R
Sponsored 3/25/2025
Deluzio
PA • D
Sponsored 3/26/2025
Luttrell
TX • R
Sponsored 3/26/2025
Keating
MA • D
Sponsored 3/26/2025
Cuellar
TX • D
Sponsored 3/26/2025
Schmidt
KS • R
Sponsored 3/26/2025
Mrvan
IN • D
Sponsored 3/27/2025
Feenstra
IA • R
Sponsored 3/31/2025
Joyce (OH)
OH • R
Sponsored 3/31/2025
Perez
WA • D
Sponsored 3/31/2025
Green (TN)
TN • R
Sponsored 3/31/2025
De La Cruz
TX • R
Sponsored 4/1/2025
Evans (CO)
CO • R
Sponsored 4/1/2025
Flood
NE • R
Sponsored 4/1/2025
Sykes
OH • D
Sponsored 4/1/2025
Kamlager-Dove
CA • D
Sponsored 4/3/2025
Franklin, Scott
FL • R
Sponsored 4/7/2025
Morrison
MN • D
Sponsored 4/7/2025
Lee (FL)
FL • R
Sponsored 4/7/2025
Torres (NY)
NY • D
Sponsored 4/8/2025
Webster (FL)
FL • R
Sponsored 4/9/2025
Gonzalez, V.
TX • D
Sponsored 4/9/2025
Mannion
NY • D
Sponsored 4/17/2025
Subramanyam
VA • D
Sponsored 4/17/2025
Steil
WI • R
Sponsored 4/17/2025
Friedman
CA • D
Sponsored 4/17/2025
Sherman
CA • D
Sponsored 4/17/2025
Torres (CA)
CA • D
Sponsored 4/17/2025
Hurd (CO)
CO • R
Sponsored 4/17/2025
Meuser
PA • R
Sponsored 4/28/2025
Gill (TX)
TX • R
Sponsored 4/29/2025
Hudson
NC • R
Sponsored 4/29/2025
Case
HI • D
Sponsored 5/5/2025
DesJarlais
TN • R
Sponsored 5/5/2025
Bynum
OR • D
Sponsored 5/5/2025
Amo
RI • D
Sponsored 5/5/2025
Gray
CA • D
Sponsored 5/5/2025
Vindman
VA • D
Sponsored 5/5/2025
Cisneros
CA • D
Sponsored 5/5/2025
Cline
VA • R
Sponsored 5/5/2025
Stefanik
NY • R
Sponsored 5/7/2025
Levin
CA • D
Sponsored 5/7/2025
Kiley (CA)
CA • R
Sponsored 5/7/2025
Weber (TX)
TX • R
Sponsored 5/7/2025
Johnson (TX)
TX • D
Sponsored 5/7/2025
Baumgartner
WA • R
Sponsored 5/15/2025
McBath
GA • D
Sponsored 5/15/2025
Veasey
TX • D
Sponsored 5/15/2025
Ciscomani
AZ • R
Sponsored 5/15/2025
Yakym
IN • R
Sponsored 5/19/2025
McDowell
NC • R
Sponsored 5/20/2025
Carbajal
CA • D
Sponsored 5/20/2025
Riley (NY)
NY • D
Sponsored 5/20/2025
Rose
TN • R
Sponsored 5/20/2025
McDonald Rivet
MI • D
Sponsored 5/21/2025
Hinson
IA • R
Sponsored 5/21/2025
Latimer
NY • D
Sponsored 5/21/2025
Stevens
MI • D
Sponsored 5/21/2025
McClain Delaney
MD • D
Sponsored 5/21/2025
Goldman (TX)
TX • R
Sponsored 5/29/2025
Soto
FL • D
Sponsored 5/29/2025
Fine
FL • R
Sponsored 6/2/2025
Rulli
OH • R
Sponsored 6/2/2025
Hoyer
MD • D
Sponsored 6/3/2025
Goodlander
NH • D
Sponsored 6/5/2025
McGuire
VA • R
Sponsored 6/23/2025
Crank
CO • R
Sponsored 6/24/2025
Rivas
CA • D
Sponsored 6/24/2025
Smith (MO)
MO • R
Sponsored 6/30/2025
Quigley
IL • D
Sponsored 7/2/2025
Carter (GA)
GA • R
Sponsored 7/2/2025
Bergman
MI • R
Sponsored 7/2/2025
Fallon
TX • R
Sponsored 7/2/2025
Shreve
IN • R
Sponsored 7/10/2025
Finstad
MN • R
Sponsored 7/14/2025
Murphy
NC • R
Sponsored 7/14/2025
Mfume
MD • D
Sponsored 7/14/2025
Fleischmann
TN • R
Sponsored 7/15/2025
Bost
IL • R
Sponsored 7/15/2025
Bacon
NE • R
Sponsored 7/16/2025
Fry
SC • R
Sponsored 7/22/2025
Ivey
MD • D
Sponsored 7/22/2025
Strickland
WA • D
Sponsored 7/23/2025
Whitesides
CA • D
Sponsored 8/1/2025
Messmer
IN • R
Sponsored 8/1/2025
Swalwell
CA • D
Sponsored 8/8/2025
Downing
MT • R
Sponsored 9/4/2025
Menendez
NJ • D
Sponsored 9/15/2025
Kim
CA • R
Sponsored 10/6/2025
Estes
KS • R
Sponsored 10/21/2025
Timmons
SC • R
Sponsored 11/18/2025
Horsford
NV • D
Sponsored 12/9/2025
Scholten
MI • D
Sponsored 12/9/2025
Larson (CT)
CT • D
Sponsored 12/10/2025
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govRelated Bills
HR1422 — Enhanced Iran Sanctions Act of 2025
Targets Iran's energy revenue through global sanctions. This bill would create a broad sanctions framework to punish foreign persons who process, export, or sell Iran-origin oil, condensates, gas, LNG, or petrochemical products. It pairs blocking of assets and visa bans with ownership-based triggers, waivers, humanitarian carve-outs, and new reporting to limit Iran's access to energy markets and finance for weapons and terrorism. - Foreign energy firms and financial institutions would face blocking of property and bans on transactions if they knowingly handle Iran-origin energy or are 50% or more owned by such actors. Associated aliens could become inadmissible and have visas revoked. - Maritime operators, insurers, flag registries, and LNG pipeline facilities would be exposed to sanctions risk when linked to Iran-origin shipments, though safety-of-crew rules and specific exemptions for imports remain. - Humanitarian organizations would keep explicit exemptions for agricultural commodities, food, medicine, medical devices, and humanitarian assistance to avoid disrupting aid. - U.S. agencies and private companies would see new duties: an interagency working group and multilateral contact group would coordinate enforcement, and private-sector reporting would be required to flag evasion and proceeds from intercepted Iran-origin energy sales.
HR842 — Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Would expand Medicare to cover multi-cancer early detection screening tests. It defines eligible tests as certain FDA-cleared or approved genomic blood tests or comparable biological-sample tests and directs the Secretary to use the national coverage determinations process to decide when they are covered.
HR909 — Crime Victims Fund Stabilization Act of 2025
Would make the False Claims Act apply to deposits to the Crime Victims Fund through FY2029. It would also require an Inspector General audit that sets the audit's scope, timing, and recipients, and the measure is titled the Crime Victims Fund Stabilization Act of 2025. - Entities that make deposits to the Crime Victims Fund would be subject to the False Claims Act (31 U.S.C. 3729–3731) for deposits from enactment through FY2029. - An Inspector General audit would examine the Crime Victims Fund and the bill would set the audit's scope, timing, and who receives the report.
HR2102 — Major Richard Star Act
Establishes concurrent receipt for retirees with combat-related disabilities. This bill would let eligible retirees receive both military retired pay and veterans' disability compensation for the same months without the offset rules that currently reduce payments. - Families of disabled retirees: Veterans with combat-related disabilities would receive both retired pay and VA disability compensation for the same months, increasing their monthly household income. - Defense and VA payment rules: The bill would amend 10 U.S.C. 1413a and 10 U.S.C. 1414 to exempt retired pay from reductions under 38 U.S.C. 5304 and 5305 and add a clear monthly no-offset rule. - Implementation and technical changes: It renames and updates chapter sections, adjusts cross-references, and applies to payments beginning the first month after enactment.
HR979 — AM Radio for Every Vehicle Act of 2025
This bill would require AM broadcast capability to be installed as standard equipment in passenger motor vehicles. It focuses on driver-accessible AM reception, allows digital AM audio to count for compliance, and links vehicle AM capability to emergency alerting through IPAWS. - Drivers and households: Built-in, driver-accessible AM reception would make it easier for people to get local AM stations and emergency alerts from their vehicles. The bill allows devices that receive digital AM to meet the requirement. - Vehicle manufacturers: The Department of Transportation would need to issue a rule within 1 year, with a general compliance deadline no later than 2 years after the rule is issued. Small manufacturers that produced no more than 40,000 passenger vehicles in 2022 would get at least 4 years to comply. - Oversight and emergency systems: States would be barred from imposing their own AM-access rules. The bill mandates interim labels and pricing protections for cars without AM, authorizes civil penalties and DOJ injunctions for violations, requires a GAO study and a congressional briefing within 1 year, and includes an 8-year sunset for the authority.
HR1262 — Mikaela Naylon Give Kids a Chance Act
Speeds and strengthens pediatric cancer drug development. It expands which cancer products companies must study in children, reshapes organ transplant network governance and fees, and adds new FDA international and transparency steps. - Children with cancer and researchers: Requires pediatric studies that produce clinically meaningful data on dosing, safety, and early effectiveness and widens the kinds of drug combinations studied. It also sets aside $25 million for pediatric drug studies in each of fiscal years 2026, 2027, and 2028. - Transplant patients and transplant network members: Changes Organ Procurement and Transplantation Network governance and financing by allowing quarterly registration fees, requiring those fees fund OPTN operations, improving electronic health record integration, and calling for a GAO review within two years. - FDA partners and drug makers: Creates an Abraham Accords Office to boost regulatory coordination and technical assistance abroad, and forces more transparency during generic (ANDA) reviews about whether generics are qualitatively and quantitatively the same as listed drugs. It also raises the Medicare Improvement Fund amount from $1.4 billion to $2.6 billion. Increases federal outlays by roughly $1.3 billion, driven by a $1.2 billion boost to the Medicare Improvement Fund and $75 million for pediatric studies, adding to federal spending.
Take It Personal
Get Your Personalized Policy View
Create a free account to save research, track policy impacts, and unlock your personalized versions of these pages.
Already have an account? Sign in